Related Experiment Videos

Hepatic artery resistance in portal vein thrombosis

F Piscaglia, S Gaiani, G Zironi

|July 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.

ESMO open·2025

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.

ESMO open·2025

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

ESMO open·2025

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC.

Abdominal radiology (New York)·2024

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Taxanes hypersensitivity is not a risk factor for severe reactions to SARS-CoV-2 vaccines.

European annals of allergy and clinical immunology·2022

See all related articles